The board of directors of ADICON Holdings Limited announced that: With effect from August 22, 2025, Mr. ZHU Jonathan ("Mr. ZHU") has been appointed as a non-executive Director and is responsible for providing professional opinion and judgment to the Board. The biographical details of Mr. ZHU are as follows: Mr. ZHU, aged 57, has extensive experience in the industrial and medical diagnostic industries. Early in his career, from 1992 to 1996, Mr. ZHU was with the US Air Force (USAF).
From June 1996 to September 1998, he was the China general manager at Environmental Elements Corporation. He then served as a senior lobbyist at EOP Group Inc. in Washington, D.C. from June 2000 to June 2005, before becoming a corporate director at HORIBA Group, a role he held from June 2005 to January 2010. From September 2014 to October 2022, he led the APAC healthcare and life sciences practice as regional managing partner at Heidrick & Struggles.
Since November 2022, Mr. ZHU has been the APAC managing partner of the life sciences practices at Korn Ferry (Sg) Pte Ltd. Mr. ZHU currently serves as a senior advisor to AdvaMed. His previous advisory appointments include senior advisor to The Carlyle Group (NASDAQ: CG) from 2019 to July 2025, and advisor to the chairman of Shenzhen Hepalink Pharmaceutical Co. Ltd. from 2020 to 2024, and member of the Asia advisory board of Coloplast from 2013 to 2021.
Mr. ZHU obtained a bachelor's degree in engineering from University of Maryland in the United States in May 1992, an MBA from University of Baltimore in the United States in May 2000 and a master's degree in laws from China University of Political Science and Law in China in 2012. With effect from August 22, 2025, Mr. ZHU has been further appointed as a member of the strategy committee of the Board.
